Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Diverse preferences for treatment options in relapsed/refractory (R/R) follicular lymphoma (FL): Survey results from patients in the United States (US)

Krish Patel, Esprit Ma, Mei Wu, Kelley Myers, Cooper Bussberg, Jayne Galinsky, Zachary Frosch

Blood (2025) 146 (Supplement 1): 6180.

https://doi.org/10.1182/blood-2025-6180

Published: 2025

Journal Articles

Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) preferred fixed-duration treatments with less frequent administrations in the era of novel bispecific antibodies (BsAbs)

Zachary Frosch, Anthony Masaquel, David Fox, Carolina Reyes, Lourenia Cassoli, Dominic Lai, Kelley Myers, Cooper Bussberg, Krish Patel

Blood (2025) 146 (Supplement 1): 6179.

https://doi.org/10.1182/blood-2025-6179

Published: 2025

Journal Articles

Patients' Preferences for Dosing Frequency and out-of-Pocket Cost Associated with Iron Chelators: A Mixed-Methods Pilot Study in the United States

Patricia Dorling, Roberta Luzzi, Alan McMichael, Cannon Kent, Elizabeth Canty, Kelley Myers, Sherif M. Badawy

Blood (2023) 142 (Supplement 1): 7203.

https://doi.org/10.1182/blood-2023-186416

Published: 2023

Journal Articles

Patient Preferences for Fixed Versus Treat-to-Progression Therapies in Chronic Lymphocytic Leukemia

Arliene Ravelo, Kelley Myers, Claire Ervin, Robyn Brumble, Cooper Bussberg, Brian Koffman, Beenish S Manzoor, Juliana M. L. Biondo, Carol Mansfield

Blood (2023) 142 (Supplement 1): 3706.

https://doi.org/10.1182/blood-2023-174719

Published: 2023

Journal Articles

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

Arliene Ravelo, Kelley Myers, Robyn Brumble, Cooper Bussberg, Brian Koffman, Beenish S. Manzoor, Juliana Biondo, Carol Mansfield

Blood (2022) 140 (Supplement 1): 10803–10805.

https://doi.org/10.1182/blood-2022-159648

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Diverse preferences for treatment options in relapsed/refractory (R/R) follicular lymphoma (FL): Survey results from patients in the United States (US)

Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) preferred fixed-duration treatments with less frequent administrations in the era of novel bispecific antibodies (BsAbs)

Patients' Preferences for Dosing Frequency and out-of-Pocket Cost Associated with Iron Chelators: A Mixed-Methods Pilot Study in the United States

Patient Preferences for Fixed Versus Treat-to-Progression Therapies in Chronic Lymphocytic Leukemia

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

Email alerts

ASH Publications

American Society of Hematology

Update search

Diverse preferences for treatment options in relapsed/refractory (R/R) follicular lymphoma (FL): Survey results from patients in the United States (US)

Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) preferred fixed-duration treatments with less frequent administrations in the era of novel bispecific antibodies (BsAbs)

Patients' Preferences for Dosing Frequency and out-of-Pocket Cost Associated with Iron Chelators: A Mixed-Methods Pilot Study in the United States

Patient Preferences for Fixed Versus Treat-to-Progression Therapies in Chronic Lymphocytic Leukemia

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only